Self-plugging microneedles offer potential to improve delivery of drugs into the eye
June 23, 2022
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Surgery
Oculis announces first patient enrolled in Phase 3 OPTIMIZE trial
June 30, 2022
OCS-01 is being reviewed for the treatment of inflammation and pain after cataract surgery, with the potential to become the first once-daily, topical and preservative-free corticosteroid for treating inflammation and pain following ocular surgery.
How quality vision builds a foundation for safety and everyday activities
June 22, 2022
As ophthalmologists observe Cataract Awareness Month this June, William L. Soscia, MD, medical director at Center for Sight, in Sarasota, Florida, focuses on the importance of having excellent vision for safety and everyday functions.
Eyelid ptosis case treated with brimonidine 0.33% gel
June 20, 2022
Researchers believe this may be the first report of the use of topical brimonidine gel for the treatment of eyelid ptosis associated with cosmetic use of botulinum toxin.
Extended depth-of-field lenses: Understanding a new player in cataract surgery
June 20, 2022
New lens types offer independence from glasses to the patient post surgery.
HelpMeSee launches eBook for manual small incision cataract surgery
June 18, 2022
According to the organization, the eBook content is designed for residents, ophthalmologists, fellows, medical students and other professionals performing or supporting cataract surgery.
MUSC dedicated surgical eye center helps manage complex cataract cases
June 15, 2022
Having a comprehensive team of ophthalmic specialists in place means patients could have multiple issues treated in a single procedure that might require two surgeries otherwise.
PANTHER Study offers 1-year results for fluocinolone acetonide intravitreal implant
June 15, 2022
The study investigates 3-year intravitreal implant in eyes with active noninfectious posterior uveitis.
Study: Artificial intelligence screenings improve eye care access in sub-Saharan Africa
June 14, 2022
The research from eye care nonprofit Orbis International focuses on diabetic retinopathy in Rwanda, where associated vision complications from diabetes are growing.
Lensar’s adaptive cataract treatment system receives FDA clearance
June 14, 2022
The systems could be in the hands of surgeons in the third quarter through a targeted initial launch, according to the company.